The board of directors of Kingworld Medicines Group Limited announced that based on the preliminary review and analysis of the unaudited consolidated management accounts of the Group and the information currently available, the Group is expected to record an increase in the profits attributable to the owners of the Company of approximately 43% to 48% for the year ended 31 December 2016 as compared with the corresponding period in 2015. The anticipated increase is mainly due to: increases in sales of products and gross profit of the Group; and a decrease in foreign exchange loss.